As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback